Amy Peterson
2019 - CytomX Therapeutics
In 2019, Amy Peterson earned a total compensation of $3.4M as President, Chief Operating Officer at CytomX Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $41,907 |
|---|---|
| Option Awards | $1,548,000 |
| Salary | $107,955 |
| Other | $1,697,861 |
| Total | $3,395,723 |
Peterson received $1.7M in other compensation, accounting for 50% of the total pay in 2019.
Peterson also received $41.9K in non-equity incentive plan, $1.5M in option awards and $108K in salary.
Rankings
In 2019, Amy Peterson's compensation ranked 3,601st out of 13,971 executives tracked by ExecPay. In other words, Peterson earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,601 out of 13,971 | 74th |
Division Manufacturing | 1,299 out of 5,701 | 77th |
Major group Chemicals And Allied Products | 450 out of 2,200 | 80th |
Industry group Drugs | 376 out of 1,886 | 80th |
Industry Pharmaceutical Preparations | 284 out of 1,398 | 80th |
Source: SEC filing on April 27, 2022.
Peterson's colleagues
We found two more compensation records of executives who worked with Amy Peterson at CytomX Therapeutics in 2019.
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019